Glatzer, Markus; Faivre-Finn, Corinne; De Ruysscher, Dirk; Widder, Joachim; Van Houtte, Paul; Troost, Esther G C; Dahele, M R; Slotman, Ben J; Ramella, Sara; Pöttgen, Christoph; Peeters, Stephanie T H; Nestle, Ursula; McDonald, Fiona; Le Pechoux, Cecile; Dziadziuszko, Rafal; Belderbos, José; Putora, Paul M. (2020). Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practice. Radiotherapy and oncology, 150, pp. 26-29. Elsevier 10.1016/j.radonc.2020.05.004
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0167814020302462-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (530kB) | Request a copy |
BACKGROUND
In limited disease small cell lung cancer (LD-SCLC), the CONVERT trial has not demonstrated superiority of once-daily (QD) radiotherapy (66 Gy) over twice-daily (BID) radiotherapy (45 Gy). We explored the factors influencing the selection between QD and BID regimens.
METHODS
Thirteen experienced European thoracic radiation oncologists as selected by the European Society for Therapeutic Radiation Oncology (ESTRO) were asked to describe their strategies in the management of LD-SCLC. Treatment strategies were subsequently converted into decision trees and analysed for agreement and discrepancies.
RESULTS
Logistic reasons, patientś performance status and radiotherapy dose constraints were the three major decision criteria used by most experts in decision making. The use of QD and BID regimens was balanced among European experts, but there was a trend towards the BID regimen for fit patients able to travel twice a day to the radiotherapy site.
CONCLUSION
BID and QD radiotherapy are both accepted regimens among experts and the decision is influenced by pragmatic factors such as availability of transportation.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Glatzer, Markus, Putora, Paul Martin |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0167-8140 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Beatrice Scheidegger |
Date Deposited: |
30 Jun 2020 17:18 |
Last Modified: |
05 Dec 2022 15:39 |
Publisher DOI: |
10.1016/j.radonc.2020.05.004 |
PubMed ID: |
32447035 |
Uncontrolled Keywords: |
BID radiotherapy QD radiotherapy SCLC decision making limited disease small cell lung cancer |
BORIS DOI: |
10.7892/boris.144504 |
URI: |
https://boris.unibe.ch/id/eprint/144504 |
Actions (login required)
 |
Edit item |